Refresh

Glenmark Pharmaceuticals Ltd. - Research Center

532296 GLENMARK Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Expenses

Material consumed

3,467.36 3,525.67 3,034.77 2,709.74 2,411.60

Manufacturing expenses

83.22 76.87 66.83 72.33 66.76

Personnel expenses

1,346.51 1,193.20 1,107.40 1,072.33 969.98

Selling expenses

353.06 323.50 240.87 318.06 357.72

Adminstrative expenses

1,497.76 1,334.13 1,227.73 1,235.94 1,171.34

Expenses capitalised

- - - - -

Cost of sales

6,747.90 6,453.36 5,677.59 5,408.40 4,977.39

Operating profit

1,472.77 1,688.22 1,890.34 1,304.23 1,327.48

Other recurring income

985.94 614.63 396.24 606.79 475.61

Adjusted PBDIT

2,458.71 2,302.85 2,286.58 1,911.02 1,803.09

Financial expenses

206.82 236.04 265.90 256.39 223.81

Depreciation

184.15 159.70 150.82 138.54 106.28

Other write offs

- - - - -

Adjusted PBT

2,067.74 1,907.11 1,869.87 1,516.09 1,473.00

Tax charges

363.11 339.66 294.31 180.10 329.88

Adjusted PAT

1,704.64 1,567.46 1,575.56 1,335.99 1,143.12

Non recurring items

-495.24 431.94 76.38 13.13 475.46

Other non cash adjustments

- - - - -

Reported net profit

1,209.40 1,999.39 1,651.93 1,349.13 1,618.57

Earnigs before appropriation

16,073.36 14,921.25 12,992.40 11,408.51 10,127.41

Equity dividend

70.54 70.54 70.54 68.03 68.03

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

16,002.82 14,850.71 12,921.86 11,340.47 10,059.38
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com